Naimish Patel - Chief Medical Officer at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Issuer Symbol
CRSP on Nasdaq
All Insider Reports
All Insider Reports

Naimish Patel - trading volume in the past year for CRISPR Therapeutics AG

Holdings reported by Naimish Patel for CRISPR Therapeutics AG

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 1,508 $49,703 $32.96 03 Apr 2025 Direct
Restricted Stock Units 25,000 30 May 2025 Direct Common Shares
Stock Option (Right to Buy) 16,500 03 Oct 2025 Direct Common Shares

Transactions reported by Naimish Patel for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.